Pharmacology of DB844, an orally active aza analogue of pafuramidine, in a monkey model of second stage human African trypanosomiasis.
Novel drugs to treat human African trypanosomiasis (HAT) are still urgently needed despite the recent addition of nifurtimox-eflornithine combination therapy (NECT) to WHO Model Lists of Essential Medicines against second stage HAT, where parasites have invaded the central nervous system (CNS). The...
Saved in:
Main Authors: | John K Thuita (Author), Michael Z Wang (Author), John M Kagira (Author), Cathrine L Denton (Author), Mary F Paine (Author), Raymond E Mdachi (Author), Grace A Murilla (Author), Shelley Ching (Author), David W Boykin (Author), Richard R Tidwell (Author), James E Hall (Author), Reto Brun (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2012-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety, pharmacokinetic, and efficacy studies of oral DB868 in a first stage vervet monkey model of human African trypanosomiasis.
by: John K Thuita, et al.
Published: (2013) -
Chemotherapy of second stage human African trypanosomiasis: comparison between the parenteral diamidine DB829 and its oral prodrug DB868 in vervet monkeys.
by: John K Thuita, et al.
Published: (2015) -
Trypanosoma brucei rhodesiense transmitted by a single tsetse fly bite in vervet monkeys as a model of human African trypanosomiasis.
by: John K Thuita, et al.
Published: (2008) -
Development of a safer laboratory vervet monkey model for the study of human African trypanosomiasis
by: Maxwell Waema, et al.
Published: (2014) -
Kenya Trypanosomiasis Research Institute cryobank for human and animal trypanosome isolates to support research: opportunities and challenges.
by: Grace A Murilla, et al.
Published: (2014)